Go Pro

Strata Skin Sciences (SSKN) Competitors

Strata Skin Sciences logo
$0.10 0.00 (0.00%)
As of 06/30/2026 02:39 PM Eastern

SSKN vs. AEMD, SONX, AMIX, IVF, and BBLG

Should you buy Strata Skin Sciences stock or one of its competitors? MarketBeat compares Strata Skin Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Strata Skin Sciences include Aethlon Medical (AEMD), Sonendo (SONX), Autonomix Medical (AMIX), INVO Fertility (IVF), and Bone Biologics (BBLG). These companies are all part of the "medical equipment" industry.

How does Strata Skin Sciences compare to Aethlon Medical?

Aethlon Medical (NASDAQ:AEMD) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

In the previous week, Aethlon Medical had 3 more articles in the media than Strata Skin Sciences. MarketBeat recorded 3 mentions for Aethlon Medical and 0 mentions for Strata Skin Sciences. Aethlon Medical's average media sentiment score of 0.58 beat Strata Skin Sciences' score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the media.

Company Overall Sentiment
Aethlon Medical Positive
Strata Skin Sciences Neutral

Aethlon Medical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Aethlon Medical's return on equity of -137.73% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Aethlon MedicalN/A -137.73% -105.87%
Strata Skin Sciences -35.64%-476.73%-33.49%

Aethlon Medical has higher earnings, but lower revenue than Strata Skin Sciences. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aethlon MedicalN/AN/A-$7.15M-$14.69N/A
Strata Skin Sciences$30.98M0.02-$10.09M-$1.41N/A

Aethlon Medical has a beta of 1.49, indicating that its share price is 49% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of -0.06, indicating that its share price is 106% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aethlon Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 0.7% of Aethlon Medical shares are held by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Aethlon Medical beats Strata Skin Sciences on 7 of the 13 factors compared between the two stocks.

How does Strata Skin Sciences compare to Sonendo?

Strata Skin Sciences (NASDAQ:SSKN) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

Strata Skin Sciences has higher earnings, but lower revenue than Sonendo. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.02-$10.09M-$1.41N/A
Sonendo$44.40M0.06-$60.92M-$71.12N/A

32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Comparatively, 7.9% of Sonendo shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Sonendo had 1 more articles in the media than Strata Skin Sciences. MarketBeat recorded 1 mentions for Sonendo and 0 mentions for Strata Skin Sciences. Strata Skin Sciences' average media sentiment score of 0.00 equaled Sonendo'saverage media sentiment score.

Company Overall Sentiment
Strata Skin Sciences Neutral
Sonendo Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Sonendo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Strata Skin Sciences has a beta of -0.06, meaning that its share price is 106% less volatile than the broader market. Comparatively, Sonendo has a beta of 2.01, meaning that its share price is 101% more volatile than the broader market.

Strata Skin Sciences has a net margin of -35.64% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
Sonendo -92.74%-184.01%-68.60%

Summary

Strata Skin Sciences beats Sonendo on 7 of the 13 factors compared between the two stocks.

How does Strata Skin Sciences compare to Autonomix Medical?

Strata Skin Sciences (NASDAQ:SSKN) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

Strata Skin Sciences has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.02-$10.09M-$1.41N/A
Autonomix MedicalN/AN/A-$16.72M-$74.58N/A

Strata Skin Sciences has a beta of -0.06, indicating that its share price is 106% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.43, indicating that its share price is 243% less volatile than the broader market.

Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 566.67%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Autonomix Medical had 3 more articles in the media than Strata Skin Sciences. MarketBeat recorded 3 mentions for Autonomix Medical and 0 mentions for Strata Skin Sciences. Autonomix Medical's average media sentiment score of 0.76 beat Strata Skin Sciences' score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Strata Skin Sciences Neutral
Autonomix Medical Positive

Autonomix Medical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Autonomix Medical's return on equity of -239.36% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
Autonomix Medical N/A -239.36%-192.46%

32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by company insiders. Comparatively, 6.2% of Autonomix Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Strata Skin Sciences beats Autonomix Medical on 8 of the 15 factors compared between the two stocks.

How does Strata Skin Sciences compare to INVO Fertility?

Strata Skin Sciences (NASDAQ:SSKN) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

INVO Fertility has a consensus target price of $20.00, indicating a potential upside of 961.01%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts plainly believe INVO Fertility is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
INVO Fertility
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

Strata Skin Sciences has higher revenue and earnings than INVO Fertility. Strata Skin Sciences is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.02-$10.09M-$1.41N/A
INVO Fertility$6.84M0.49-$25.13M-$1.85 thousandN/A

Strata Skin Sciences has a beta of -0.06, suggesting that its stock price is 106% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.33, suggesting that its stock price is 133% more volatile than the broader market.

In the previous week, INVO Fertility had 4 more articles in the media than Strata Skin Sciences. MarketBeat recorded 4 mentions for INVO Fertility and 0 mentions for Strata Skin Sciences. INVO Fertility's average media sentiment score of 0.89 beat Strata Skin Sciences' score of 0.00 indicating that INVO Fertility is being referred to more favorably in the news media.

Company Overall Sentiment
Strata Skin Sciences Neutral
INVO Fertility Positive

32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 12.0% of INVO Fertility shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Comparatively, 0.4% of INVO Fertility shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Strata Skin Sciences has a net margin of -35.64% compared to INVO Fertility's net margin of -183.75%. INVO Fertility's return on equity of -420.62% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
INVO Fertility -183.75%-420.62%-45.21%

Summary

INVO Fertility beats Strata Skin Sciences on 9 of the 16 factors compared between the two stocks.

How does Strata Skin Sciences compare to Bone Biologics?

Strata Skin Sciences (NASDAQ:SSKN) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Bone Biologics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 34.3% of Bone Biologics shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Comparatively, 7.5% of Bone Biologics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Strata Skin Sciences has a beta of -0.06, indicating that its stock price is 106% less volatile than the broader market. Comparatively, Bone Biologics has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market.

In the previous week, Bone Biologics had 1 more articles in the media than Strata Skin Sciences. MarketBeat recorded 1 mentions for Bone Biologics and 0 mentions for Strata Skin Sciences. Bone Biologics' average media sentiment score of 1.87 beat Strata Skin Sciences' score of 0.00 indicating that Bone Biologics is being referred to more favorably in the news media.

Company Overall Sentiment
Strata Skin Sciences Neutral
Bone Biologics Very Positive

Bone Biologics has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Bone Biologics' return on equity of -50.47% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
Bone Biologics N/A -50.47%-47.40%

Bone Biologics has lower revenue, but higher earnings than Strata Skin Sciences. Bone Biologics is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.02-$10.09M-$1.41N/A
Bone BiologicsN/AN/A-$3.11M-$2.27N/A

Summary

Bone Biologics beats Strata Skin Sciences on 7 of the 12 factors compared between the two stocks.

Get Strata Skin Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SSKN vs. The Competition

MetricStrata Skin SciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$589K$1.79B$6.80B$12.55B
Dividend YieldN/AN/A2.66%6.16%
P/E Ratio-0.0480.7127.4225.27
Price / Sales0.027.84542.60102.53
Price / CashN/A24.8348.5358.59
Price / Book0.085.6811.006.57
Net Income-$10.09M-$54.76M$3.57B$336.82M
7 Day PerformanceN/A5.56%2.69%2.31%
1 Month PerformanceN/A-1.26%1.85%-0.12%
1 Year PerformanceN/A4.70%36.85%30.30%

Strata Skin Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SSKN
Strata Skin Sciences
N/A$0.10
flat
N/A-95.6%$589K$30.98MN/A120
AEMD
Aethlon Medical
1.1058 of 5 stars
$1.36
-1.4%
N/A-93.1%$3.27MN/AN/A10
SONX
Sonendo
N/A$0.60
flat
N/AN/A$2.87M$44.40MN/A250
AMIX
Autonomix Medical
2.9611 of 5 stars
$0.36
-5.5%
$42.00
+11,599.2%
-81.1%$2.62MN/AN/A1
IVF
INVO Fertility
2.5089 of 5 stars
$1.37
-1.4%
$20.00
+1,359.9%
-98.3%$2.48M$6.84MN/A10

Related Companies and Tools


This page (NASDAQ:SSKN) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners